Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
BMC Health Services Research|March 27, 2025
Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New ZealandLynne Chepulis, Mark Rodrigues, Han Gan, et al.Diabetologia|October 23, 2023
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data InfrastructureNicholas Bowden, Rachael Dixon, Vivienne Anderson, et al.Cell Death and Differentiation|April 8, 2017
Pore-forming toxin-mediated ion dysregulation leads to death receptor-independent necroptosis of lung epithelial cells during bacterial pneumoniaNorberto González-Juarbe, Kelley Margaret Bradley, Anukul Taranath Shenoy, et al.BMJ Open|September 3, 2020
Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocolRui Qian Yeu, Rebecca Brandon, Yannan Jiang, et al.JMIR Diabetes|May 28, 2026
Exploring User Experiences With the Lift App for Emotional Well-Being Among Youth With Type 1 Diabetes: Qualitative StudyKatie M Babbott, Kristin Harrison Ginsberg, Anna L Boggiss, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2021
Learning challenges of healthcare professionals supporting open-source automated insulin deliveryHamish Crocket, Dana M Lewis, Mercedes Burnside, et al.Journal of Diabetes Science and Technology|July 3, 2025
First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 DiabetesTom Wilkinson, Solita Donnelly, Claire Lever, et al.Journal of Diabetes and Metabolic Disorders|March 5, 2026
Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: the ACCESS-AID study protocolJennifer T Gale, Alisa Boucsein, Jonathan Williman, et al.Journal of Diabetes and Metabolic Disorders|May 30, 2023
Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trialMercedes Burnside, Tracy Haitana, Hamish Crocket, et al.The New Zealand Medical Journal|August 1, 2024
Diabetes treatment satisfaction among a multi-ethnic Aotearoa New Zealand population with uncontrolled type 2 diabetes mellitusRy Yves Tweedie-Cullen, Yannan Jiang, Rebecca Brandon, et al.Pageof 9